Insights

Providing the latest information from our experts at Forge
January, 31 2024 in Articles
Comprehensive Characterization of Plasmid and AAV Gene Therapy Products with Forge Biologics’ Hybrid Sequencing Approach

Comprehensive characterization of plasmid and AAV gene therapy products with Forge...

October, 17 2023 in Articles
Starting With the End in Mind

Starting With the End in Mind

September, 13 2023 in Articles
Genes of Interest

Genes of Interest, our employee spotlight showcasing the individuals behind Forge that...

December, 1 2022 in Articles
Streamline the AAV Manufacturing Process with High-Grade Starting Materials

 Streamline the AAV Manufacturing Process with High-Grade Starting Materials Authors:

November, 3 2022 in Articles, Videos
What the DMF! Spotlight on Forge's Drug Master File

Gene therapy developers' Investigational New Drug (IND) application process is arduous...

August, 12 2022 in Articles
Addressing the ‘Capacity Crunch’ with a Scalable Platform Process Approach

Authors: Brianna Barrett, Ph.D., Associate Director, Technical Sales, Forge Biologics ...